Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
pralsetinib
×
Clear all
Filters
2
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts
NCT04760288
2024-01-05
AcceleRET-MTC
Hoffmann-La Roche
Phase 3
Withdrawn